From: Juvenile idiopathic arthritis in two tertiary centres in the Western Cape, South Africa
Study | Morocco4 | Turkey6 | Printo2W. Europe | Printo2E. Europe | Printo2Latin America | India5 | South Africa |
---|---|---|---|---|---|---|---|
N | 80 | 196 | 2102 | 668 | 397 | 235 | 78 |
Age current | 10.85* | 8.8* | 9.4* | 11.4* | 10.7* | 13(12.4*) | |
Age at onset | 7.53* | 7.0* | 5.4* | 6.8* | 6.6* | 12 | 8(7.3*) |
Female | 59% | 47% | 83% | 72% | 68% | 41.7% | 50% |
Systemic | 26% | 15.3% | 16.4% | 23% | 28.5% | 8% | 7.69% |
Polyarthritis | 31.5% | 37.2% | 32% | 33% | 40.6% | 29% | 40.9% |
Poly RF+ | 6.6% | 12% | 14% | ||||
Poly RF- | 30.6% | 17% | 26.9% | ||||
Oligo Persistent | 37,5% | 24.4% | 29.5% | 31.6% | 21.9% | 17% | 21.8% |
Oligo extended | 5% | 9.6% | 21.5% | 12% | 9% | 4% | 5% |
ERA | 10.3% | 36% | 23% | ||||
Psoriatic | 1% | 1% | 1.28% | ||||
Undifferentiated | 2.5% | 5% | |||||
VAS pain(mm) | 28.4* | 28* | 23* | 27* | 18(24.9*) | ||
VAS general(mm) | 25* | 28* | 24* | 25(28.4*) | |||
Limited joints | 1.78* | 5.9* | 8.6* | 10.1* | 2(6.51*) | ||
Active joints | 4.39* | 5.3* | 6.7* | 7.1* | 2(3.85*) | ||
CHAQ | 0.84* | 0.7* | 0.6* | 0.8* | 0.5(0.73*) | ||
ESR | 28* | 30.7* | 27.7* | 31.2* | 14 (25.1*) |